Spiriva (tiotropium) is a prescription drug used to treat specific breathing conditions. Spiriva’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy ...

Please provide your email address to receive an email when new articles are posted on . A Montreal Cognitive Assessment score of 16 or less, which implies dementia, predicted errors in using inhalers.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause your breathing to suddenly get worse (bronchospasm). If this happens, use your rescue inhaler, stop taking SPIRIVA, and call your doctor right away or ...

Inhalers like Spiriva and Advair are too expensive for many Medicare beneficiaries with chronic obstructive pulmonary disease, reports Kaiser Health News. Here are four things to know. 1.

Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...

When I read the news that three out of four manufacturers of asthma and COPD inhalers have decided to cap the price to the patient to no more than $35 a month, it came as a shockingly pleasant ...

WASHINGTON, Sept 23 (Reuters) - The blockbuster inhaled lung medication Spiriva, marketed by Pfizer Inc and Boehringer Ingelheim, raises the risk of heart attack, stroke and death from heart disease, ...

A recent tweak to a Medicaid formula could be behind the shake-up to inhaler products, a series of changes that have both benefited and harmed patients with asthma and chronic obstructive pulmonary ...

LONDON (Reuters) - Results of a clinical study to be presented next month show the blockbuster inhaled lung drug Spiriva, marketed by Pfizer and Boehringer Ingelheim, actually cuts heart risk, ...

Lupin of India has become the first company to score approval in the U.S. for its generic version of Boehringer Ingelheim’s blockbuster COPD treatment Spiriva HandiHaler. The FDA has signed off on ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...

When Theravance called it quits on a phase 2 JAK inhibitor program last February, the South San Francisco and Dublin-based biopharma company put the majority of its chips on a head-to-head trial ...